JACKILYN BYRD: Open Payments
NPI 1982273975 · MOREHEAD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 18 payments from 11 companies in 2025. Trend: 2023 $224 · 2024 $127 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: SUBLOCADE, VRAYLAR, CAPLYTA, AIRSUPRA, Auvelity, Dexcom G6 Transmitter, REXULTI, INVEGA SUSTENNA.
Industry payments across KY — which companies pay providers there.
